Cita APA (7a ed.)
Frank, S., Hames, K. C., Jbaily, A., Park, J. H., Stroyeck, C., & Price, D. (2022). Feasibility of Using a Factory-Calibrated Continuous Glucose Monitoring System to Diagnose Type 2 Diabetes. Diabetes Technology & Therapeutics, 24(12), 907-915.
Cita Chicago Style (17a ed.)
Frank, Spencer, Kazanna C. Hames, Abdulrahman Jbaily, Jee Hye Park, Chuck Stroyeck, y David Price. "Feasibility of Using a Factory-Calibrated Continuous Glucose Monitoring System to Diagnose Type 2 Diabetes." Diabetes Technology & Therapeutics 24, no. 12 (2022): 907-915.
Cita MLA (9a ed.)
Frank, Spencer, et al. "Feasibility of Using a Factory-Calibrated Continuous Glucose Monitoring System to Diagnose Type 2 Diabetes." Diabetes Technology & Therapeutics, vol. 24, no. 12, 2022, pp. 907-915.
Precaución: Estas citas no son 100% exactas.